Role of gingival lymphatics in tissue fluid balance and periodontal disease development by Mkonyi, Lilian E.
Role of gingival lymphatics in tissue  fluid balance 
and periodontal disease development  
 
Lilian E. Mkonyi 
 
Dissertation for the degree philosophiae doctor (PhD)  
at the University of Bergen 
 
2012 
 2
 
                                                Dissertation date: 25.05.2012 
 3
Abstract 
Background: The gingiva is frequently challenged to oral bacteria which are able to 
induce inflammatory responses with increased fluid filtration and edema formation in 
the tissue. Under given circumstances periodontal pathogens can also promote 
periodontal disease characterized by bone resorption. Lymphatic vessels drain fluid 
from the interstitium and transport lymphocytes and antigen-presenting toward lymph 
nodes to elicit immune responses. In gingiva, lymphatic vessels are found, but their 
function in transcapillary fluid balance and their role in periodontal disease 
development was hitherto unknown. 
Methods and Results: We demonstrated that the mouse model of lymphedema, the 
K14-VEGF receptor 3-Ig (K14) mice, lacked gingival lymphatic vessels and had an 
almost absence of lymphatics in the mucosal layer of alveolar mucosa. We therefore 
used this transgenic mouse model to investigate the role of gingival lymphatics 
intranscapillary fluid balance in steady state situation and after perturbation of the 
tissue. The gingiva of K14 mice had significantly higher interstitial fluid pressure 
(Pif) in normal situation and after inflammation-induced by lipopolysaccharide (LPS) 
from Porphyromonas gingivalis (P. gingivalis) compared with wild type (WT) 
controls. Overhydration caused more than 75% increase in interstitial fluid volume 
(IFV) followed by a drop in Pif after recovery in both strains. Continuous 
measurements during the expansion showed an increase in Pif followed by a decline, 
suggesting that compliance is increased during edema formation. In the alveolar 
mucosa, no strain differences were observed in Pif and IFV in any situation, 
suggesting that mucosal lymphatics are not critical for tissue fluid regulation. 
 Using WT mice, we further demonstrated that lymphatic growth take place in 
gingiva after P. gingivalis oral gavage. The lymphatics area fraction was increased in 
infected mice at both 10 and 42 days postinfection and modest bone loss was verified 
in the longest observation period, whereas proliferation of vessels was observed only 
in the shortest observation period. Higher numbers of immune cells expressing 
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vascular endothelial growth factor (VEGF)-C along with upregulation of IL-1 and 
TNF- at protein levels were found in infected mice 10 days after infection. 
We also demonstrated that K14 mice developed significantly more bone loss 42 days 
after infection with P. gingivalis. The mutant mice had also higher level of G-CSF, 
IL-1 and IFN- in periodontal tissues as well as increased number of macrophages 
and antigen presenting cells in bone resorptional areas compared to WT mice. 
However, significantly lower plasma level of P. gingivalis specific IgG was found in 
infected K14 mice compared to infected WT littermates. Our data demonstrate that P. 
gingivalis infection induced a strong periodontal inflammatory response accompanied 
by a weakened systemic humoral B-cell response in K14 mice. 
Conclusion: Gingival lymphatics are crucial for transcapillary fluid balance in the 
steady-state condition and during acute perturbation. Lymphangiogenesis takes place 
in gingiva during periodontal disease development and up-regulation of VEGF-C in 
recruited immune cells is likely important for the growth of lymphatic vessels. 
Moreover, gingival lymphatic vessels protect against P. gingivalis induced 
periodontitis, probably by enhancing clearance of bacterial products and promoting 
humoral immune responses.  
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1. INTRODUCTION 
1.1 The gingiva 
The periodontal tissues (periodontium) represent the supporting structures of the teeth 
(Bartold, Walsh et al. 2000). Tissues which form periodontium are gingiva, 
periodontal ligament, cementum and alveolar bone Fig. 1. 
Gingiva which is also part of the masticatory mucosa surrounds the cervical neck 
of the tooth and is divided into free gingiva and attached gingiva. The free gingiva is 
relatively mobile and extends from the gingival margin to the base of gingival sulcus. 
The attached gingiva is firmly attached to the tooth and alveolar bone by dense 
collageneous fiber bundles and forms the bulky portion of the gingiva. The attached 
gingiva extends apically from free gingiva to merge with mucosa of the hard palate 
on the palatal aspect or adjacent alveolar mucosa on the vestibular and lingual aspect. 
The interdental gingiva is free gingiva that occupies the space between the adjacent 
teeth (Schroeder and Listgarten 1997). 
 
 
 
                    
                
                     
          Figure 1. Schematic illustration of the periodontium. Modified from 
http://www.dental.pitt.edu/informatics/periohistology/en/gu0102.ht)  
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The gingival epithelium is divided into oral epithelium, sulcus epithelium and 
junctional epithelium. The oral epithelium is a stratified, squamous epithelium 
comprised of layers of cells which lose their nuclei as they grow toward the surface. 
It lines the external surfaces of the gingiva and forms a physical barrier to oral 
bacteria. The sulcus epithelium is a parakeratinized stratified squamous epithelium 
that lines the lateral surface of the gingival sulcus. The junctional epithelium is a 
nonkeratinizing stratified epithelium in contact with the sulcus epithelium and 
thegingival connective tissue (Fig.1), and it forms the floor of the gingival sulcus 
(Schroeder and Listgarten 1997). The cells of the junctional epithelium have wide 
intercellular spaces between them, which makes the junctional epithelium more 
permeable than gingival and sulcus epithelium. As a results the junctional epithelium 
is a preferential route for bacteria/bacterial products from sulcus to the gingival 
connective tissue, and for fluid from the connective tissue to the sulcus (crevicular 
fluid) (Tanaka 1984). These morphological characteristics of the junctional 
epithelium 
make the gingival tissue highly susceptible to external agents that can lead to 
inflammation (Marchetti, Poggi et al. 1999). 
The gingival connective tissue, also known as lamina propria, is found 
underneath the epithelium. The lamina propria is made of a network of dense 
collagen fiber bundles; the supra-alveolar fiber apparatus. The fiber apparatus, which 
is mainly composed of collagen Type I and III, provides gingival attachment to the 
tooth and alveolar bone and gives gingiva the rigidity and resilience against 
masticatory forces (Narayanan and Page 1983). In the connective tissue lies the 
ground substance, fibroblasts, immune cells such as lymphocytes, macrophages and 
some plasma cells (Schroeder and Listgarten 1997). In addition, numerous blood 
vessels and also lymphatic vessels are present in the tissue (Marchetti, Poggi et al. 
1999). The blind- ended lymphatics travel in the lamina propria toward the alveolar 
crest and pass along the external surface of the alveolar bone (Marchetti, Poggi et al. 
1999; Ushijima, Inoue et al. 2008), as demonstrated in Fig. 2. 
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Figure 2. Localization of lymphatic vessels in gingiva in WT mice. The lymphatic vessels were identified 
by double labeling with Lymphatic vessel endothelial hyaluronan receptor (LYVE-1) and podoplanin 
antibodies, both markers for lymphatic endothelium. 
1.2 Lymph drainage 
Lymphatic vasculature maintains tissue homeostasis by carrying fluid and protein 
from the interstitial space and returns them to the blood circulation and is also a 
trafficking route for extravasated leukocytes and antigens. Activated antigen-
presenting cells travel in lymphatic vessels towards the draining lymph nodes where 
they initiate adaptive immune responses. Lymphatic vessels are also involved in fat 
absorption from the digestive system (Alitalo, Tammela et al. 2005; Tammela and 
Alitalo 2010).  
The lymphatic capillaries originate in the interstitium as blind-ended vessels and 
are the smallest vessels in the lymphatic vasculature. The lymphatic capillaries are 
made of a continuous single layer of overlapping endothelial cells and lack a 
continuous basement membrane making them highly permeable. They are attached to 
the extracellular matrix by anchoring filaments which keep them open during periods 
of increased interstitial fluid pressure and thus facilitate fluid drainage (Tammela, 
Petrova et al. 2005; Baluk, Fuxe et al. 2007; Maby-El Hajjami and Petrova 2008). 
Lymphatic capillaries carry the lymph to the collecting ducts. The collecting ducts 
unlike the lymphatic capillaries are surrounded by smooth muscle cell layer, have 
basement membrane and posses valves that prevent lymph backflow. From here the 
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lymph passes through the chain of lymph nodes and eventually reach the systemic 
circulation via the thoracic duct (Alitalo, Tammela et al. 2005). 
Failure of lymph transport results in accumulation of fluid and protein in the 
interstitial space with eventual edema formation. The protein- rich fluid in the tissue 
initiates an inflammatory reaction leading to fibrosis and accumulation of fat. 
Impairment of lymphatic vessels function also weakens immune responses and 
increases the host’s susceptibility to infection  (Rockson 2001; Witte, Bernas et al. 
2001; Alitalo, Tammela et al. 2005). 
There are several lymphatic endothelial cells specific markers that enable the 
characterization and tissue localization of lymphatics. Among them are the vascular 
endothelial growth factor receptor 3 (VEGFR-3) (Kaipainen, Korhonen et al. 1993); 
podoplanin, a membrane mucoprotein (Breiteneder-Geleff, Soleiman et al. 1999); 
lymphatic endothelial hyaluronan receptor-1(LYVE-1), a hyaluronic acid receptor  
(Banerji, Ni et al. 1999) and the prospero-related homeobox gene-1(Prox-1), a 
transcription factor (Wigle and Oliver 1999). Some of these lymphatic markers have 
been used this thesis. 
1.3 Interstitial fluid pressure and transcapillary fluid 
balance 
Interstitial space is the space that surrounds the cells of tissues. This space has a solid 
component; the extracellular matrix and a fluid component; the interstitial fluid. The 
interstitial fluid together with the blood plasma constitutes the extracellular fluid. 
Interstitial fluid acts as a medium through which nutrients from the blood plasma 
diffuse and can be taken up by the cells. Furthermore, waste products from the cells 
pass through the interstitial fluid and are absorbed into the blood capillaries. In this 
way interstitial fluid allows the communication between the cells and blood plasma 
which is crucial for cells vitality and normal function (Aukland and Nicolaysen 
1981). 
Fluid is transported between the blood vessels and the interstitial space. This 
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fluid flow is governed by Starling forces namely, hydrostatic pressure (P) and colloid 
osmotic pressure (COP) (Starling 1896). The Starling forces can be summarized in 
the following equation: 
           (Jv) = CFC [(Pc - Pif) -  (COPc - COPif)]-L  
The Jv is net fluid flux across the capillary, CFC is the capillary filtration 
coefficient, Pc is the capillary blood pressure, Pif is the interstitial fluid pressure,  is 
the reflection coefficient for proteins, COPc and COPif are the colloid osmotic 
pressures in plasma and interstitial fluid, respectively and L is the lymph flow. 
 Under normal situation the Pif  is lower than the Pc; this pressure difference 
creates a hydrostatic force which favors filtration of fluid into the interstitial space. 
On the other hand, since the capillary wall acts as a semipermeable membrane, the 
plasma proteins are retained inside the vessels. Consequently, the concentration of 
proteins will increase and create a higher COPc than COPif, which encourage fluid 
absorption into the vessels. 
CFC is the constant of proportionality and is a product of capillary surface area 
and capillary hydraulic conductance. A high CFC value indicates that the capillary 
wall is highly water permeable whereas the low value indicates low permeability. The 
reflection coefficient for proteins  is a factor which describes the permeability to 
proteins of capillary wall. If the vessel is impermeable for proteins, the  equal to 1 
whereas  = 0 shows that the vessel is freely permeable for proteins. 
 
Under control condition, the net filtration of fluid (Jv), is balanced by equal lymph 
flow (L), and therefore a constant interstitial fluid volume (IFV) is maintained. 
However, if the Jv is increased (either by an increase in hydrostatic pressure or 
decrease in oncotic pressure) above the lymph flow, the IFV will increase. The latter 
may be followed by an increase in Pif which may prevent or reduce edema 
generation, depending upon the compliance of the tissue (Aukland and Reed 1993). 
 
Interstitial compliance is defined as the change in IFV (IFV) divided by the 
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corresponding change in Pif (Pif) (Guyton 1965). Interstitial compliance is an 
important factor for the IFV regulation as it determines how much Pif will change in 
response to changes in IFV. In a tissue with a relatively low interstitial compliance, 
a modest increase in IFV resulting from an increase in capillary filtration, will lead 
to a rise in Pif and thereby counteract further capillary filtration. 
Measurement of  Pif in a low compliant tissue such as dental pulp (Tonder and 
Kvinnsland 1983; Heyeraas, Kim et al. 1994; Berggreen and Heyeraas 1999), brain 
(Wiig and Reed 1983), rat tail (Aarli and Aukland 1991), hard palate and attached 
gingiva (Johannessen, Fjartoft et al. 1987; Fjaertoft, Johannessen et al. 1992) ; and 
PDL (Kristiansen and Heyeraas 1989) demonstrated Pif to be higher compared to 
the tissues with high compliance such as skin and muscle, which have Pif below 
ambient pressure (Aukland and Reed 1993). 
In normal conditions, Pif  was about 3.5 mm Hg in rat free gingiva and ranged 
from 6.0 to 7.4 mm Hg in attached gingiva (Aarli and Heyeraas 1991; Fjaertoft, 
Johannessen et al. 1992). A significant rise in Pif after gingival inflammation induced 
by tooth-ligation have been demonstrated in rats (Fjaertoft, Johannessen et al. 1992) 
and in rabbits (Del Fabbro, Francetti et al. 2001) . 
The findings demonstrated that gingiva is a relatively low compliant tissue, 
meaning that a fluid volume increase is reflected in an elevated Pif. The increase in 
Pif during inflammation is a result of an increased fluid filtration from capillaries to 
the interstitium due increase in Pc and/or to an increase capillary permeability. Del 
Fabbro et al. (Del Fabbro, Francetti et al. 2001), further showed that during 
inflammation, proteins were accumulating in the crevicular fluid derived from 
inflamed gingiva and /or from dental plaque bacteria, which create a pressure 
gradient driving fluid from the gingiva interstitium into the sulcus area (Del Fabbro, 
Francetti et al. 2001). In addition to increased crevicular fluid formation, it is also 
likely that gingival lymph flow increases in this situation due to the increased Pif. The 
role, however, of lymphatic vessels in regulation of transcapillary fluid balance in 
gingiva during steady state or during periods of increased fluid filtration, was not 
investigated and at the time unknown. 
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1.4 The K14-VEGFR3-Ig mouse model 
A K14-VEGFR3-Ig  mouse is a genetically engineered mouse model in which the 
ligand-binding domain of vascular endothelial growth factor receptor (VEGFR)-3 
fused to the Fc-region of human immunoglobulin  chain,  is overexpressed under the 
control of the keratin-14 promoter in the basal keratinocytes of the skin (Makinen, 
Jussila et al. 2001).  
The soluble VEGFR-3 inhibits the binding of vascular endothelial growth factor-
C (VEGF-C)/VEGF-D ligands to their endogenous receptor VEGFR-3, resulting in 
hypoplasia of dermal lymphatic vessels. The K14-VEGFR3-Ig mice have visible 
swelling of the limbs due to lymphatic vessel regression in the skin, whereas the 
growth of blood vessels is not affected (Makinen, Jussila et al. 2001). The keratin -14 
gene is also expressed in the epithelial cells of all parts of the oral mucosa (Barrett, 
Selvarajah et al. 1998).  
1.5 Lymphangiogenesis 
Lymphangiogenesis is the formation of new lymphatic vessels from preexisting 
vasculature. It occurs when lymphatic endothelial cells sprout, migrate and proliferate 
to form new lymphatic capillaries. Lymphatic vessel growth also involves vessel 
enlargement resulting from proliferation of lymphatic endothelial cells without 
sprouting and migration. (Jeltsch, Kaipainen et al. 1997; Tammela, Saaristo et al. 
2005). 
During embryonic development lymphatic vasculature arises from the blood 
vasculature by sprouting from cardinal veins (Oliver 2004; Srinivasan, Dillard et al. 
2007), a process which involves Prox-1 and VEGF-C as the key players (Wigle and 
Oliver 1999; Karkkainen, Haiko et al. 2004). In adults, lymphatic vessels grow 
during physiological wound healing, but it has also been associated with 
inflammation and tumour growth (Achen, McColl et al. 2005; Alitalo, Tammela et al. 
2005). The formation of new lymphatics in inflamed tissue facilitate the drainage of 
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accumulated interstitial fluid  and clear up leukocytes and cytokines (Mouta and 
Heroult 2003). However, lymphangiogenesis has been shown to actively participate 
in maintance of chronic inflammatory diseases (Cueni and Detmar 2006) and is 
demonstrated in rejected renal transplants (Kerjaschki, Regele et al. 2004; Kerjaschki 
2006), in psoriatic skin lesions (Kunstfeld, Hirakawa et al. 2004), in joints with 
inflammatory arthritis (Zhang, Lu et al. 2007), in ulcerative colitis (Kaiserling, 
Krober et al. 2003) as well as in chronic airway inflammation (Baluk, Tammela et al. 
2005). 
Adult lymphangiogenesis takes place mainly by sprouting from pre-existing 
lymphatics  and is mediated  by VEGF-C and VEGF-D  after they bind to their 
lymphatic endothelial receptor, VEGFR- 3 (Alitalo, Tammela et al. 2005). These 
lymphangiogenic factors are derived mainly from  immune cells such as 
macrophages, but resident tissue cells such as fibroblasts and keratinocytes also 
secrete the factors (Ristimaki, Narko et al. 1998). The VEGF-A, which is mainly a 
proangiogenic factor, can also promotes lymphangiogenesis by binding to VEGFR- 2 
expressed in low level in lymphatic endothelium (Lohela, Bry et al. 2009). In 
addition, VEGF-A recruits inflammatory cells to the inflamed tissue, which secrete 
VEGF-C and VEGF-D (Schoppmann, Birner et al. 2002; Cursiefen, Chen et al. 
2004). 
There are other growth factors such angiopoietin -1 (Morisada, Oike et al. 2005; 
Tammela, Saaristo et al. 2005), fibroblast growth factor -2 (Chang, Garcia-Cardena et 
al. 2004), hepatocyte growth factor (Kajiya, Hirakawa et al. 2005), insulin-like 
growth factor- 1 and 2 (Bjorndahl, Cao et al. 2005) and platelet derived growth 
factors (Cao, Bjorndahl et al. 2004) which also promote lymphatics growth  indirectly 
via the VEGF-C/VEGFR-3 signaling pathway.Besides vessel sprouting, new 
lymphatic vessels can be generated from bone marrow–derived cells such as 
macrophages which transdifferentiate into lymphatic endothelial cells (Maruyama, Ii 
et al. 2005). 
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1.6  Periodontal diseases 
Periodontal diseases are chronic inflammatory conditions caused by bacterial 
infection of the periodontium. The diseases are initiated by accumulation of bacterial 
plaque in the gingival sulcus adjacent the root surface of the tooth (Figure 3). The 
pathogenic bacteria in the plaque  produce a wide range of virulence factors which 
penetrate the gingival epithelium and the underlying connective tissue (Pihlstrom, 
Michalowicz et al. 2005).  
Although the bacterial products can directly damage the host’s tissues, most of 
tissue destruction occurs by the stimulation of host’s immune response resulting in 
secretion of inflammatory mediators such cytokines and chemokines into the tissues 
(Graves 2008; Preshaw 2008). These mediators increase blood vessel permeability 
causing fluid to move from the vascular compartment into the interstitium which can 
results in edema formation (Page 1986). Furthermore, the inflammatory mediators 
reinforce the recruitment of various inflammatory cells including neutrophils, 
macrophages and lymphocytes which further release more of the pro-inflammatory 
cytokines into the connective tissues (Taubman, Valverde et al. 2005; Graves 2008; 
Preshaw 2008; Hernandez, Dutzan et al. 2011). 
 In most cases the host responses cause reversible tissue destruction and the 
condition is termed gingivitis. In some instances, however, gingival inflammation 
continue and lead to irreversible breakdown of periodontal tissues including alveolar 
bone  a condition called periodontitis (Graves, Oates et al. 2011). 
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Figure 3. Diagrammatic representation showing healthy and diseased periodontium. Note the 
accumulation of immune cells, dilated blood vessels, presence of bone resorbing-osteoclasts and loss of 
alveolar bone in diseased side. 
 
1.7 Porphyromonas gingivalis 
Bacterial plaque initiates periodontal diseases but which species cause the irreversible 
breakdown of periodontal tissues is still controversial (Pihlstrom, Michalowicz et al. 
2005; Sakamoto, Umeda et al. 2005). There are certain organisms in the bacterial 
plaque which have been demonstrated to have a strong relationship with periodontal 
disease development. Among them P. gingivalis, a gram-negative black-pigmented 
anaerobe bacteria commonly associated with chronic periodontitis in human adults 
(Lamont and Jenkinson 1998; Holt and Ebersole 2005; Silva, Dutzan et al. 2008; 
Byrne, Dashper et al. 2009). 
P. gingivalis possesses several virulence factors which are important for 
successful bacterial invasion and survival inside the host`s periodontal tissue. These 
include proteases that degrade proteins to peptides and provides bacterial nutrition, 
fimbriae which is important for the bacterial attachment to various host components 
and the lipopolysaccaride (LPS) which is essential for the bacteria`s structural and 
functional integrity (Lamont and Jenkinson 2000; Tribble, Mao et al. 2006). 
However, these virulence factors cause direct damage to the tissues of the 
periodontium as well as stimulate host immune responses (Graves 2008; Liu, Lerner 
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et al. 2010).The latter  ment to eliminate the bacterial infection, but have also been 
shown to contribute to the periodontal tissue destruction (Lamont and Jenkinson 
1998; Yilmaz 2008). 
P. gingivalis proteases such as gingipains are able to degrade tissue proteins and 
peptides and thereby damage tissue integrity (Stathopoulou, Galicia et al. 2009; 
Taylor 2010). In addition, the protein digestion by the gingipains not only destroy 
cytokines  and thus  weakens the host immune responses against the microbes 
(Stathopoulou, Benakanakere et al. 2009), but also induces cytokine secretion in host 
cells via the cleavage and activation of protease-activated receptors (Lourbakos, 
Potempa et al. 2001; Uehara, Imamura et al. 2008).  
P. gingivalis has two forms of fimbriae (major form A and the minor form Mfa,). 
The major form A interact with various host cells and induces cytokine secretion and 
modulates immune responses (Hajishengallis, Sojar et al. 2004). For example, major 
fimbriae inhibit IL-12 secretion (Hajishengallis, Shakhatreh et al. 2007) , a cytokine 
which is important for activation of natural killer cells and CD8+ cytotoxic T-cells. 
These T-cells are important for killing of P. gingivalis infected cells and the lack of 
their activation will therefore promote survival of the organism (Hajishengallis and 
Harokopakis 2007; Wang, Shakhatreh et al. 2007). 
 LPS is a major component of the outer membrane of gram negative bacteria and 
is important for the bacterial integrity (Raetz and Whitfield 2002; Nikaido 2003). It 
consists of O- antigen polysaccharide, a core oligosaccharide and lipid A. Lipid A, 
also known as endotoxin, is a biologically active region of LPS which is responsible 
for activation of immune responses (Jain and Darveau 2010). When the bacteria 
interact with the host cells, their components are recognized by toll-like receptors 
(TLRs), a group of pattern-recognition receptors which are expressed on various cells 
of  immune and non-immune cell types, thereby governing immune responses (Akira 
and Takeda 2004; Gribar, Richardson et al. 2008).  LPS is commonly recognized by 
TLR-4 which in addition requires molecules such as CD14 and MD-2 to form a 
complex that triggers intracellular signaling cascade resulting in the release of pro-
inflammatory cytokines (Mahanonda and Pichyangkul 2007). The structure of P. 
gingivalis LPS is different from that of the much studied Escherichia coli  (Ogawa 
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1993). P. gingivalis LPS is heterogeneous, with variation in the lipid A structure 
(Diya, Lili et al. 2008) allowing to signal mainly via TLR-4 and sometimes through 
TLR-2 (Darveau, Pham et al. 2004). The lipid A from this microbe is capable of  
antagonizing the action of agonist forms of P. gingivalis LPS as well as the agonist 
activity of LPS from other bacterial species thus enabling the pathogen to evade 
immune responses and persist in the oral tissue (Jain and Darveau 2010). 
1.8 Host immune response and contributions to 
periodontal diseases 
Both the innate and adaptive immune responses are crucial for protecting the host 
against invading pathogens (Garlet, Cardoso et al. 2007; Garlet, Cardoso et al. 
2008).However, during periodontal infection activation of  leukocytes from both 
arms of immunity results in the expression  of various inflammatory mediators such 
as cytokines which are capable of stimulating alveolar bone resorption and soft tissue 
destruction via host-derived matrix metalloproteinases (MMPs) (Garlet, Martins et al. 
2004; Goncalves, Oliveira et al. 2008). In addition, receptor activator of nuclear 
factor kappa-B ligand (RANKL), a key mediator of the alveolar bone destruction is 
also upregulated (Garlet, Martins et al. 2004; Cochran 2008) . RANKL binds to the 
its receptor RANK, found on the surfaces of pre-osteoclasts leading to their 
maturation and activation.OPG is a decoy receptor that inhibits the binding of 
RANKL to RANK and  thus hinders bone resorption  (Leibbrandt and Penninger 
2008). 
The innate immune responses are initiated after the bacterial components are 
recognised by TLRs which are present on resident cells and leukocytes (neutrophils 
and monocytes/macrophages)  in the periodontal tissues (Mahanonda and 
Pichyangkul 2007). Activation of these receptors stimulates intracellular signalling 
cascade leading to activation transcription factors including nuclear factor-k B (NF-
kB) and to subsequence release of various inflammatory cytokines and chemokines 
(Gelani, Fernandes et al. 2009; Lima, Gelani et al. 2010). Innate immunity cytokines 
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such as TNF-, IL-1, and IL-6 are host mediators produced after microbial 
recognition and which have been associated with the enhanced RANKL production, 
osteoclastogenesis and  connective tissue and alveolar bone destruction (Graves 
2008). Neutrophils and monocytes/macrophages also release enzymes such as 
elastases and collagenases which cause degradation of  the connective tissue (Lee, 
Aitken et al. 1995). Besides production of inflammatory mediators subset of 
monocytes have been shown also to express RANK on their surface and  serve as pre-
osteoclastic cells (Chapple, Srivastava et al. 1998; Leon, Martinez del Hoyo et al. 
2004; Mormann, Thederan et al. 2008).  
  The adaptive immune response is also initiated by the invading microbe through 
activation of  TLRs found on the surface of antigen presenting cells, particularly 
dendritic cells (Cutler and Jotwani 2004). The dendritic cells capture and process the 
pathogen and present the bacterial peptides to lymphocytes. The dendritic cells also 
release cytokines and chemokines that determine the differentiation of the naïve T 
helper (Th) cells into appropriate mature effector cells (Cutler and Jotwani 2004). 
Initially Th cells were divided into two subclasses Th1 and Th2 according to the 
pattern of the cytokines they produce (Murphy and Reiner, 2002). Recently two more 
subsets of  Th cells have been discovered namely Th17 and Tregs  (Appay, van Lier 
et al. 2008). Both these subsets are found in periodontal lesions suggesting their 
involvement in pathogenesis of periodontal disease (Garlet, Martins et al. 2003; 
Gemmell and Seymour 2004; Honda, Domon et al. 2006; Cardoso, Lobato et al. 
2009).   
Th1 lymphocytes secrete IFN- and are associated with cellular immunity. IFN- 
activates macrophages which are important for killing of microorganisms, but these 
cells also produce TNF- and IL-1 which participate in alveolar bone destruction 
(Gao, Grassi et al. 2007; Garlet, Cardoso et al. 2008). Th2 cells are involved in 
humoral immune responses and secrete IL-4 among other cytokines. IL-4 is crucial 
for stimulation of B cell and antibody production (Murphy and Reiner 2002; Appay, 
van Lier et al. 2008; Sallusto and Lanzavecchia 2009).  The B cells also secrete 
RANKL in response to oral bacteria (Han, Lin et al. 2009), and in periodontal lesions 
they express RANKL (Kawai, Matsuyama et al. 2006) suggesting their involvement 
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in alveolar bone destruction. Th17 lymphocytes are characterized by their production 
IL-17 which in turn induces production of RANKL (Kotake, Udagawa et al. 1999; 
Sato, Suematsu et al. 2006) and MMPs by secreting  IL-6 and induce TNF- and IL-
1 upregulation (Beklen, Ainola et al. 2007). 
1.9 Cytokines 
Cytokines are small soluble proteins that are secreted by variety of cell types. Their 
primary function is to regulate host immune responses in diseases, but they are also 
involved in many biological activities such as cell growth and differentiation, 
inflammation and repair (Okada and Murakami 1998; Seymour and Gemmell 
2001).Most cytokines are produced upon cell activation and usually act locally on the 
target cells. They exert their effect at very low concentrations (picomolar) in an 
autocrine or paracrine fashion.  
Cytokines act by binding to high affinity surface receptors on target cells and 
initiate intracellular signaling cascades that alter cell functions through the up-
regulation and/or down-regulation of several genes and their transcription factors. As 
a results, specific proteins are produced which can be involved in a variety of 
biological activities, including inflammation (Schindler 1999; Handfield, Baker et al. 
2008; Preshaw and Taylor 2011). 
Included in the cytokine group are the interleukins, interferons, tumor necrosis 
factor family and chemokine family which are crucial for leukocyte migration. In 
addition, growth factors and adipokines, such as transforming growth factors- (TGF-
) and , leptin are capable of modifying immune responses and thus, are also 
considered as cytokines (Preshaw and Taylor 2011).  
Cytokines are divided into pro-inflammatory and anti-inflammatory cytokines. 
Pro-inflammatory cytokines are those cytokines produced during an inflammatory 
response which favors its progression. Included in this group are the major cytokines 
interleukin-1 (IL-l), IL-6, IL-8, and tumor necrosis factor-  (TNF-). Other pro-
inflammatory cytokines are IL-12, IL-18, interferon- (IFN- ) and granulocyte-
macrophage colony stimulating factor (GM-CSF).  
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In contrast, anti-inflammatory cytokines suppress the inflammation process, by 
their ability to suppress gene expression for pro-inflammatory cytokines and further 
counteract the effects of inflammatory mediators (Dinarello 2000). Anti-
inflammatory cytokines includes IL-4, IL-10, IL-13, IL-16 and TGF- (Dinarello 
2000). 
It should be noted that, most of immune cytokines tend to have both pro-and anti-
inflammatory activity (Dinarello 2000) and  further they interact and work in network 
to drive immune responses necessary for host protection. However, if disruption of 
this network occurs it can lead to destructive inflammation observed in many 
pathological conditions including periodontal diseases (Preshaw and Taylor 2011). 
The outcome of inflammatory response is therefore determined by a balance between 
the effects of pro- and anti-inflammatory cytokines (Dinarello 2000; Preshaw and 
Taylor 2011).  
1.10 Mouse periodontitis model  
It is difficult to establish causal relationships between various factors and periodontal 
tissues breakdown by using human studies (Graves, Fine et al. 2008), therefore the 
use of animal models has provided useful information about different aspects of host-
bacteria interaction and disease process (Graves, Fine et al. 2008). A mouse 
periodontitis model was developed to assess the alveolar bone resorption after oral 
bacterial infection (Baker, Evans et al. 1994). In this model, the mouse is initially 
treated with antibiotic to reduce murine normal flora and is then orally infected by a 
human strain of oral bacteria such as P. gingivalis (Fig. 4). The alveolar bone loss 
around the molars is detected 6 weeks or more after bacterial challenge either 
histologically, or with morphometric analysis or  microcomputed tomography (Hart, 
Shaffer et al. 2004; Wilensky, Gabet et al. 2005; Garlet, Cardoso et al. 2006). 
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Figure 4. In a mouse periodontitis model mice are pretreated with antibiotics, orally infected with 
bacteria and observed for 6 weeks before they are sacrificed 
1.11 Rational of the thesis 
Gingiva is constantly challenged by bacteria and changes in the host responses in 
addition to the pathogenicity of the microflora, frequently leads to inflammatory 
processes. The lymphatic system in gingiva has previously been under-investigated 
due to the lack of specific lymphatic markers which made it difficult to differentiate it 
from the blood vessels. As a result little was known about the functional effect of the 
lymphatic system in gingiva in health and disease. Therefore, the focus of this thesis 
has been to investigate lymphatic function in normal situation and its function and 
responses after onset of periodontal disease.  
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2. AIMS OF THE THESIS 
2.1  GENERAL AIMS 
The overall aim of this thesis was to investigate the role of gingival lymphatics for 
tissue fluid balance and during development of periodontal disease. 
2.1.1 SPECIFIC AIMS 
To describe the phenotype of oral mucosa in the K14-VEGFR3-Ig mouse model, 
(Paper I). 
To determine the functional effects of missing gingival lymphatics in relation to 
tissue fluid balance in steady state condition and after fluid overload, (Paper I). 
To investigate the role of gingival lymphatics during acute inflammation, (Paper I). 
To study if lymphangiogenesis occur in inflamed gingiva during development of 
periodontal disease, (Paper II). 
To investigate if lack of lymphatics in gingiva may cause altered immune responses 
and affect alveolar bone resorption after bacterial challenge with P. gingivalis (Paper 
III). 
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3. METHODS 
Here, experimental material and methods are briefly presented. Detail descriptions of 
specific procedure are found in individual papers. 
3.1 Animals 
Experiments were performed in male and female K14 mice (Paper I, III) and wild 
type mice (Paper I, II, and III) both of C57/Bl6 background. The mice were housed in 
polycarbonate cages at the animal facility unit and received a standard food pellets 
and tap water ad labium.  The mutation in K14 mice was verified by PCR analysis 
prior to the experiments. The housing unit was temperature controlled (22 ± 2 C) 
with a constant 12-hour light and 12-hour darkness cycle. All the experiments were 
performed according to the recommendations outlined by Norwegian State 
Commission for Laboratory Animals with the local ethical committee’s approval. 
Anesthesia: In paper I, mice were anesthetized intramuscularly with a 1:1 mixture 
(0.1ml/10g body wt) of midazolam (Dormicum, Roche, France) and 
fentanyl/fluanison (Hypnorm; Janssen). In paper II and III isoflurane was 
administered for 2 min during the oral gavage of the bacteria.  In all three papers 
mice were sacrificed with an overdose of anaesthesia. 
3.2 Measurement of interstitial fluid pressure (Paper I) 
Pif  was measured by the micropunture method  (Wiig, Reed et al. 1981) using a 
sharpened glass capillaries (micropipettes) with tip diameter of  2-6 	m filled with 
colored 0.5 M NaCl. Under the guidance of a stereomicroscope the micropipettes 
were inserted into the gingiva and alveolar mucosa with a micromanipulator at a 
depth of 200-600 μm below the surface. The micropipettes were connected to a 
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servo-controlled counter-pressure system and Pif was measured by the counter 
pressure method developed by Wiederhielm and collaborators (Wiederhielm, 
Woodbury et al. 1964). 
3.3  Systemic blood pressure recordings  (Paper I) 
Systemic blood pressure was continuously measured in the femoral artery which was 
first exposed and then cannulated with polyethylene catheter connected to a pressure 
transducer and recorder.  
3.4  Measurements fluid volume (Paper I) 
Fluid volumes were determined using 51Cr-EDTA and 125I- labeled human serum 
albumin. Total extracellular fluid volume (Vx) was measured using 51Cr-EDTA as the 
extracellular marker. 51Cr-EDTA distributes uniformly in the plasma and interstitial 
fluid without uptake in cells (Løkken, 1970). A bolus of intravenous (i.v) injection of 
51Cr-EDTA was given, and the tracer was then infused (i.v) continuously during an 
equilibrium period (90 min) to compensate for loss in urine.  125I-HSA was used as 
the intravascular marker to measure intravascular volume (Vv). 125I-HSA was allowed 
to circulate for 5 min only before the blood was collected (Linderkamp, Holthausen 
et al. 1977). Blood samples, alveolar and masticatory mucosa were weighed and the 
radioactivity was counted.  IFV of the tissues was calculated as the difference 
between Vx and Vv. 
3.5 Experimentally induced overhydration (Paper I) 
The effect of increased volume in a tissue with reduced lymphatic drainage capacity 
was studied by measuring the Pif  response. By using an infusion pump, Ringer 
solution corresponding to 15% of body weight was infused through right femoral 
artery over a period of 30 min. Pif was measured in the attached gingiva and alveolar 
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mucosa of anesthetized mice in the control situation before the infusion and after a 
30-min equilibration period. In separate groups, mice were infused with isotopes (as 
described above) to determine volume distribution after overhydration. In a separate 
group of WT mice, Pif was measured continuously in the attached gingiva during 
fluid expansion and recovery period. 
3.6 Acute inflammation induction (Paper I) 
Pif was  recorded for 10 min in the attached gingiva before induction of gingival 
inflammation using injection of  LPS from P. gingivalis (1 	l LPS (5 mg/ml, 
InvivoGen, San Diego, CA, USA) in experimental group or equivalent volume of 
vehicle (1 	l of 0.9% NaCl with 1% bovine serum albumin (BSA)) in controls. 
Thereafter Pif was continuously measured for 90 min, before mice were sacrificed 
with an overdose of anaesthesia. 
3.7 Collagen fiber visualization and content  (Paper I)  
 Collagen fibers were visualized under polarizing light in 6	m thick paraffin 
embedded sections stained with Picro-Sirius Red. Measurement of collagen content 
in the alveolar mucosa and masticatory mucosa was based on hydroxyproline content 
(Woessner 1961). The absorbance was read at 557 nm on a spectrophotometer 
(Molecular Devices, Sunnyvale, CA). Quantification of hydroxyproline concentration 
was done by comparison to a standard curve of L-4- hydroxyproline (Fluka Chemise 
GmbH, Bucks, France) in 1mM Hal. Collagen content was calculated based on a 6.94 
to 1 collagen to hydroxyproline ratio (Jackson and Cleary 1967). 
3.8 Oral infection with P. gingivalis (Paper II,III) 
Periodontal infection was induced in WT mice (Paper II) and in both strains of mice 
(Paper III) by  P. gingivalis ATCC 53978 (W50) oral gavage (Baker, Evans et al. 
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1994). Briefly, mice were treated with antibiotics in drinking water for 10 days to 
reduce oral flora, followed by a 4-day antibiotic-free period. P. gingivalis suspended 
in 100 μL PBS with 2% carboxymethylcellulose (CMC; Sigma) was given to 
experimental animals while controls received the vehicle CMC without the bacteria. 
Ten days (Paper II) and forty-two days (Paper II, III) after the last gavage tissue and 
blood samples were harvested for further analysis. 
 
3.9 Enzyme-linked immunosorbent assay (Paper II,III) 
Specific serum IgG to P. gingivalis ATCC 53978 (W50) was measured by ELISA 
(Baker, Evans et al. 1994). A ninety six well polystyrene plates were coated 
overnight  with formalin-killed bacteria followed overnight incubation at 4°C of  
serial dilutions (2-fold) of test or positive control sera (22 to 212 or 214). The plates 
were washed and the bounded antibody was detected using alkaline phosphatase–
conjugated goat anti-mouse IgG antibodies (Paper II, III). The reaction was quantified 
by P-nitrophenyl phosphate substrate and absorbance was determined at OD405 by 
microplate reader. In addition, the level of different cytokines in the periodontal 
tissue was detected using commercially available ELISA kits obtained from R&D 
Systems (DuoSets, Minneapolis, USA) according to the manufacturer’s instructions ( 
Paper II and III).   
3.10 Alveolar bone loss (Paper II,III) 
Assessment of horizontal bone loss was performed by the morphometric method .The 
maxillary jaws were defleshed, stained with 1% methylene blue and positioned so 
that the occlusal face of the molars was perpendicular to the base. Images of the 
buccal view of the jaws were captured under a stereomicroscope equipped with a 
digital camera. Using Lucia imaging software, alveolar bone loss was measured 
directly as the distance from cementum–enamel junction (CEJ) to the alveolar bone 
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crest (ABC) (Paper II) or as a polygonal area made by tracing the CEJ, marginal ABC 
of the three molars, and the distal margin of the visible root of 3rd molar and the 
mesial margin of the visible root of 1st molar (Paper III).  
3.11 Immunohistochemistry (Paper I,II,III) 
In paper I, mice were transcardiacally perfused through the aorta with heparinized 
saline followed by 4% paraformaldehyde with 0.2% picric acid. The jaws were post-
fixed for 2 hr at 4 ºC and then decalcified in EDTA for 7 days. In papers II and III 
jaws were collected and immediately decalcified in EDTA for 4 days without 
fixation. All jaws were soaked in 30% sucrose overnight, sectioned (8-20μm) and 
stored at -80 ºC. The sections were used for immunoperoxidase staining, using a 
Vectastain ABC kit, or for immunofluorescence staining. Sections from EDTA 
treated jaws were acetone fixed for 10 min on the glass before immunostaining 
procedures. Peroxidase activity was developed with 3, 3`-diaminobenzidine and 
enhanced with nickel. 
The following antibodies were used; mouse monoclonal antibody to human IgG Fc 
domain (dilution 1:1000),  rabbit anti-mouse LYVE-1 (dilution 1:1000), syrian 
hamster anti-mouse podoplanin (dilution 1: 50),  rat anti-mouse CD3 (dilution 1:500), 
rat anti-mouse CD4 (dilution 1:500),  rat anti-mouse CD8 (dilution 1: 50), rat anti-
mouse CD 20 (dilution 1:200),  rat anti-mouse CD31 (dilution 1:50), rat anti-mouse 
CD45 (dilution 1:500), rat anti-mouse CD31 (dilution 1:100), rat anti-mouse CD4 
(dilution 1:100) , rat anti-mouse Ki-67 (dilution 1:50), rat anti-mouse Ly-6B.2 
(dilution 1: 4000) and rat anti-mouse MHC class II (dilution 1:1500), goat polyclonal 
anti-mouse VEGF-C (dilution 1:50) and VEGF-A (dilution 1:50 ), rabbit anti-mouse 
VEGF-D (dilution 1:50). 
The corresponding secondary antibodies for immunofluorescense includes CyTM3-
conjugated IgGs (dilution1:200), Alexa Fluor 488, Alexa Fluor 555 and Alexa Fluor 
647conjugated species-specific (dilution 1:250) used for visualization of the immune 
reactions.  Controls of the specificity of the immunoreactions were included by 
isotype control immunoglobulin incubation and by substitution of the primary 
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antiserum with PBS. Sections were evaluated in a photomicroscope or in a 
fluorescent microscope. 
3.12 Quantification of gingival  immune cells (Paper I,II,III) 
Immunolabeled cells counts were performed in the gingival connective tissue mesial 
to first molar and in the papillas between the molars in a grid (150 	mX100 	m) 
under the light microscope, connected to a digital camera using Lucia imaging 
software.  In paper II, VEGF-C +/CD45+ cells were counted in gingival lamina 
propria mesial to 1st and distal to 3rd molars using a  in a 100 	mX200 	m grid.  The 
pooled value for each animal was obtained by averaging the number of positive 
stained cells detected in three to five sections. 
 
3.13 Quantification of lymphatic and blood vessels (Paper 
II) 
Lymphatic and blood vessels were identified 10 days post-infection using LYVE-1 
and CD31 immunofluorescent double labeling and images captured using a digital 
camera. In addition, LYVE-1 positive lymphatics were identified with the ABC 
method forty two days after infection. Lymphatic and blood vessels area fraction 
was evaluated by Lucia imaging software (Lucia v.145 480, Laboratory Imaging, 
Hostiva, Check Republic) in the connective tissue of the gingiva (mesial to 1st and 
distal to 3rd) molars. The area fraction was calculated as the ratio between the area 
occupied by lymphatics or blood vessels and the total tissue area (	m2).The vessel 
profiles per area in the same areas were also obtained. 
3.14 RNA isolation and quantitative RT-PCR (Paper II) 
Total RNA was extracted from the gingival tissues using the RNeasy® mini kit 
(Qiagen; Chatsworth, CA).The quality control was analyzed by 1% agarose gel 
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electrophoresis.  RNA concentration was quantified by a spectrophotometer. 2μg of 
total RNA was used for the reversed transcription into cDNA using synthesis kit 
(Fermentas GmbH, Germany). Primers for detection of VEGF-C and VEGF-D were 
added to eighty nanograms of cDNA and then Q-PCR reactions were performed 
using iQ SYBR Green Supermix (BioRad) in LightCycler 480®. VEGF-A gene 
expression was quantified by using a pre-designed TaqMan® gene expression assay 
(Applied Biosystems) and a TaqMan Universal PCR Master Mix (Applied 
Biosystems). All samples were assayed in triplicate and normalized to Gapdh content.  
3.15 TRAP staining (Paper III) 
Histochemical analysis using tartrate resistant acid phosphatase (TRAP) staining was 
performed in order to quantify osteoclasts and their precursors. The TRAP+ cells 
were counted in a grid (100x200μm) placed on top of the approximal bone between 
the molars.  
3.16 Multiplex analysis (Paper III) 
The concentration of cytokines in the periodontal tissues was measured using a 
multiplex kit (Millipore Corporation, Billerica, MA, USA). A panel of the following 
cytokines was simultaneously quantified: G-CSF, IFN-, IL-10, IL-17, IL-1, IL-2, 
IL-6, IP-10, KC, M-CSF, MIP-1 , RANTES and TNF-  according to 
manufacturer’s instructions. Total surface fluorescence was measured with a flow –
based dual laser system (Luminex 100, Luminex corporation, Austin, TX, USA) for 
the detection of different colour-coded beads and quantitation of cytokines. 
Cytokines concentration was calculated with reference to standard curve based on 
broad range of standards (4.8- 20 000 pg ml-1) provided in the kit. 
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3.17 Flow Cytometry of immune cells in cervical lymph 
nodes  
After the dissection, the cervical lymph nodes were incubated with 0.28 Wunsch 
units/ml of Liberase thermolysin medium ™ for 50 min at 37°C, to liberate 
leukocytes. The cells were filtered through a 70-	m filter ,  washed three times in 
PBS and  incubated for 30 min at 4 °C with the following conjugated antibodies for 
antigen detection: Pacific BlueTM CD4 (1: 25), PE CD8 (1:25), APC CD19 (1: 50), 
PerCP-CYTM5.5 CD11c (1: 25), FITC F4/80 (1:25) and Alexa Fluor® 700 Ly-6B.2 
(1: 10) .Cells were washed again and approximately 300,000 cells were analyzed by 
flow cytometry.  Negative controls were unstained cells from lymph nodes, and for 
control of gate settings each antibody was incubated with microparticles from an anti-
rat Ig / negative Control Compensation Particles Set. 
3.18 Statistical analysis 
Results were given as means± SD or SEM. Student’s t test or Mann Whitney-test was 
used for comparison between two groups (paper I and II) and analysis of variance 
(ANOVA) for comparisons between more than two groups (paper I and III) followed 
by Holm-Sidak or Bonferroni post-hoc tests. For repeated pressure measurements 
within a group and between groups, data were analysed with one-way repeated 
measures analysis of variance (RM-ANOVA) (paper I). P < 0.05 was considered 
statistically significant in all three papers.  
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4. SUMMARY OF THE RESULTS 
4.1 Paper I 
In this paper, the role of initial lymphatics in gingival transcapillary fluid balance 
was investigated in genetically engineered K14 mice. Immunohistochemistry 
showed that lymphatic vessels were absent in gingiva of K14 mice. On contrary, in 
alveolar mucosa lymphatics were present in the submucosal area but were almost 
completely absent in the mucosa. Blood vessel distribution, tissue histology and 
collagen content in masticatory mucosa and alveolar mucosa in K14 mice were 
normal, indicating that only lymphatic vasculature was defected in the mutant mice. 
 K14 mice had increased Pif in gingiva in normal situation and after gingival 
inflammation induced by P. gingivalis LPS compared to WT mice. Furthermore, 
overhydration resulted in increased tissue volume by more than 75% in both strains, 
followed by a drop in Pif after recovery. When Pif   was continuously measured in the 
gingiva during overhydration, an increase in Pif was observed in early phase of fluid 
expansion followed by a decline. In alveolar mucosa, there was no significant 
difference neither in Pif  nor IFV between the strains under normal situation and after 
fluid volume expansion. 
 Immunohistochemical analysis of immune cells in the masticatory mucosa using 
CD3, CD4, and CD45 markers revealed that the CD45+ cell number was significantly    
higher in K14 mice compared to WT mice. However, T cell (CD3+ and CD4+) 
numbers were similar in both strains. 
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4.2 Paper II 
In this study, we investigated if lymphangiogenesis occurs in inflamed gingiva during 
periodontal disease development. Gingival inflammation was induced in mice by P. 
gingivalis oral gavage and the animals were observed for 10 and 42 days.  
Immunostaining with LYVE-1 demonstrated that lymphatic vessel area fractions 
were significantly increased in infected mice compared to sham mice, whereas the 
profiles were not different between the groups 42 days post-infection. LYVE-1+ / 
CD45+ leukocytes were also detected close to LYVE-1+ vessels in infected mice. The 
infected mice had also significantly greater CEJ-ABC distances 42 days post-
infection than sham mice, demonstrating that bone loss had occurred. 
Immunofluorescent labeling with LYVE-1 and CD31 showed that lymphatic and 
blood vessel area fractions and profiles in the gingiva were increased 10 days post-
infection. The lymphangiogenic response was shown in infected mice by the presence 
of LYVE-1+/Ki-67+ endothelial cells. 
VEGF- C protein was expressed in epithelial cells and CD45 + immune cells in 
gingiva in both groups of mice 10 days post-infection. VEGF-D and VEGF-A 
staining was found in the epithelium and also in a few CD45+ immune cells.VEGF-A 
protein was also expressed in blood vessels. The VEGF-C+/CD45+ cell number in 
lamina propria was significantly higher in infected mice than sham 10 days post-
infection. Gene analysis revealed that the expressions of VEGF-A and D were 
significantly down-regulated, whereas that of VEGF-C was slightly increased but not 
statistically significant at 10 days post-infection. 
Higher levels of pro-inflammatory cytokines IL-1 and TNF- were found in the 
infected mice 10 days post infection, but only TNF- was statistically significant 
elevated.  
 40
4.3  Paper III 
This study was undertaken to investigate if lack of gingival lymphatics in K14 mice 
may cause altered immune responses and alveolar bone resorption 42 days after P. 
gingivalis challenge. The results demonstrated that infected K14 mice had 
significantly more alveolar bone loss compared to their own shams as well as to WT 
infected mice. No signinificant difference in bone loss was found within the WT 
strain.    
 TRAP+ cell number on the alveolar bone surface tended to be higher in K14 
infected mice but was not significantly different compared to K14 shams as well as 
infected WT. 
The number of F4/80+ cells and MHC class II + cells in the gingival connective 
tissue of infected K14 mice were significantly higher compared to infected WT mice. 
Numerous CD20+ B cells were also found close to the alveolar bone in infected K14 
mice, however their number was not significantly different compared to infected WT 
mice. Few neutrophils were found adjacent to the alveolar bone, but in two infected 
K14 mice a periodontal abscess surrounded by neutrophils was found, suggesting a 
more severe infection in the K14 strain. 
The level of the cytokines IFN-, IL-1 and G-CSF were significantly elevated in 
infected K14 mice compared to infected WT mice. The M-CSF level was 
significantly higher in K14 sham compared to WT sham and was also high in both 
infected strains.  
The levels of P. gingivalis specific IgG in the serum were elevated in both strains 
after infection , but significantly lower IgG levels was found in infected K14 mice 
than in infected WT mice.  
There were no significant differences in immune cell distribution in cervical 
lymph nodes between the strains in any condition. 
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5. GENERAL DISCUSSION 
Lymphatic vessels are present in the gingiva (Ushijima, Inoue et al. 2008), a tissue 
which is frequently associated with inflammatory responses due to infectious disease.  
Yet, the function of lymphatic vessels in transcapillary fluid balance and during 
development of periodontal disease was hitherto unknown. In this thesis therefore, 
the role of gingival lymphatic vessels in transcapillary fluid exchange in normal and 
during periods of increased fluid filtration was investigated. Additionally, we 
investigated whether lymphangiogenesis occurs during development of periodontal 
disease. Finally, the function of lymphatic vessels during periodontal disease 
development was also investigated. 
5.1 The role gingival lymph vessels in transcapillary fluid 
exchange 
In paper I, we demonstrated that K14 mice lack lymphatics in the gingiva, whereas in 
the alveolar mucosa lymphatics were found in the submucosal layer and almost 
completely absent in the mucosal layer. 
The K14 mice had significantly higher Pif in the gingiva compared to WT mice in 
the normal situation. The finding indicates that there is accumulation of fluid in the 
gingival interstitium of K14 mice, resulting in a higher Pif Pif .The latter counteract 
further fluid filtration into the interstitium and a new steady state is established. 
Furthermore, injection of LPS in the gingiva resulted in an increase in Pif in both 
strains of mice, which remained significantly higher in K14 mice compared to WT 
mice. This finding suggests increased fluid filtration into the interstitium in LPS 
induced inflammation, and the fluid accumulated to a greater extent in K14 mice 
where lymphatics were missing in gingiva. Together, these results demonstrate that 
gingival lymphatics play an important role in tissue fluid homeostasis in the gingiva 
in both conditions. 
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The finding that overhydration led to increase of IFV by more than 75% in the 
masticatory mucosa (gingiva included) in both strains, which was accompanied by 
fall in Pif in the gingiva, was an unexpected observation. Pif is expected to rise in 
response to increase IFV in order to prevent further fluid filtration across the 
capillary. We therefore decided to continuously measure Pif during the infusion and 
recovery period. We observed a rise in Pif in the early phase of fluid loading, which 
was followed by a drop in Pif as the infusion continued. A likely explanation for this 
observation is ; as overhydration continued there was increased filtration which 
resulted in fluid accumulation in the extracellular space, followed by rise in Pif. 
Because the cells and extracellular matrix components are bound together by integrin 
receptors which keep them in tension (Hynes 1992) we speculate that the rise in Pif 
may have lead to perturbation of the receptors and thus release of the tension between 
the cells and the matrix. This will result in an increase in tissue compliance followed 
by a drop in Pif (Wiig, Rubin et al. 2003). The drop in Pif will further enhance fluid 
filtration out of the capillary and lead to increase in IFV, as observed in our 
experiments. Antibody blocking of integrin receptors has been demonstrated to be 
followed by lowering of Pif and oedema formation (Reed, Laurent et al. 1996). We 
speculate that the edema we observed was caused by disruption of the extracellular 
matrix, a hypothesis that is supported by Negrini et al., who found that fluid 
expansion that caused drop in Pif and edema formation in the lung, was associated 
with loss of interaction between proteoglycan and other extracellular matrix 
components (Negrini, Tenstad et al. 2006). 
We could not measure difference in IFV in the masticatory mucosa between 
strains in any conditions. One possible explanation is that the higher Pif in the 
gingiva 
in the mutant mice creates pressure gradients which favour fluid flux toward the 
alveolar mucosa and also into the gingival sulcus. Increased fluid conductance in the 
gingival interstitium in K14 mice may also take place, as it has been demonstrated 
that tissue conductance is increased in tissue with lymphatic vessel impairment 
(Hedbys and Mishima 1962; Guyton, Scheel et al. 1966). An increased conductance 
may favour fluid movement toward the alveolar mucosa in the mutant mice and 
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thereby contribute to reduce the IFV in the masticatory mucosa. Lack of sensitivity 
in our method and inclusion of palatinal mucosa with lymphatics in the submucosal 
layer, may also be a reason for not detecting IFV differences between the strains. 
In the alveolar mucosa, there were no significant differences neither in Pif nor in 
IFV in K14 mice compared to WT mice in any situation. This may be due to the 
presence of lymphatics in the submucosal layer which can compensate for impaired 
lymph drainage of mucosal lymphatic vessels.  
Lymphangiogenesis in periodontal disease  
The main finding in paper II was that oral infection with P. gingivalis resulted in 
lymphatic vessel growth which was accompanied by angiogenesis. In addition to 
increase in both vascular area fractions and profiles 10 days post-infection, there was 
also presence of LYVE-1+/Ki-67+ endothelial cells in the gingiva of infected mice.  
The observation indicates that lymphatic vessel proliferation take place in the first 
weeks after infection in this periodontitis model. The growth of lymphatics in 
inflamed gingiva may promote lymph flow and antigen presentation, and contribute 
to protect mice from severe inflammation. This speculation is supported by our recent 
finding in paper III, where the mutant K14 mice developed severe inflammation 
accompanied by increased alveolar bone loss after P. gingivalis  infection. 
The lymphatic area fraction remained significantly increased 42 days post-
infection (paper II). Persistent enlarged lymphatic vessels have also been 
demonstrated in Mycoplasma pulmonis (M. pulmonis) infected airways in which 
elimination of bacteria by antibiotic treatment did not regress the enlarged lymphatics 
vessels (Baluk, Tammela et al. 2005). However, the reason for the resistance of 
lymphatics regression is unknown (Yao, Baluk et al. 2010). 
The finding that infected mice had higher numbers of CD45+ immune cells 
expressing VEGF-C protein 10 days post-infection, suggests that these cells 
contribute to the lymphangiogenic response. Similar findings that inflammatory cells 
secrete VEGF-C which promoted lymphangiogenesis were observed in mice with 
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chronic airway inflammation induced by M. pulmonis infection (Baluk, Tammela et 
al. 2005) 
The VEGF-C activation of VEGFR-3 expressed in lymphatic endothelium is 
followed by proliferation of these cells (Makinen, Veikkola et al. 2001; Wirzenius, 
Tammela et al. 2007). Mature form of VEGF-C can also bind and activates VEGFR-2 
expressed in lymphatics and in blood vessels (Joukov, Sorsa et al. 1997; Wirzenius, 
Tammela et al. 2007). VEGF-D+ and VEGF-A+ proteins were strongly expressed in 
the epithelial layer and in some few immune cells in gingiva (paper II). VEGF-A 
staining was also found in gingival blood vessels.  However, the gene expression for 
VEGF-D and A was down-regulated and the number of immune cells expressing 
VEGF-D and VEGF-A was not different after bacterial challenge.  P. gingivalis has 
been reported to induce gene down regulation in an early phase after infection 
(Sasaki, Okamatsu et al. 2004), possibly through inhibition of cell activation or 
induction of apoptosis. Several studies have shown apoptosis in vitro (Johansson and 
Kalfas 1998) and in vivo (Isogai, Isogal et al. 1996; Graves, Oskoui et al. 2001) and 
affect various cells as epithelial cells, fibroblasts and immune cells. 
The elevated expression of TNF- and IL-1 in the infected mice 10 days post-
infection indicates ongoing inflammatory responses. Both cytokines, have been 
shown to promote lymphangiogenesis by inducing gene expression of  VEGF-C 
(Ristimaki, Narko et al. 1998). TNF- also activates recruited immune cells and may 
therefore further reinforcing their role in lymphangiogenesis (Baluk, Yao et al. 2009). 
5.2  The role of gingival lymph vessels in periodontal 
disease  
In paper III, we showed that K14 mice which lack gingival lymphatics exhibit 
significantly more alveolar bone loss compared to WT mice 42 days after 
P.gingivalis infection. The increased bone loss in infected K14 mice was 
accompanied by increased number of macrophages and MHC II antigen presenting 
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cells adjacent to alveolar bone. Furthermore, the level of IL-1, IFN- and G-CSF in 
the gingival tissue in transgenic mice was also increased compared to infected WT 
mice. 
Macrophages produce several cytokines that stimulate destruction of connective 
tissue and alveolar bone (Graves 2008).  Among them, IL-1 is involved in alveolar 
bone destruction through stimulating RANKL expression in osteoblasts and 
lymphocytes (Kwan Tat, Padrines et al. 2004). IL-1 induces also production of 
colony stimulating factors (Bagby, Dinarello et al. 1986; Tanabea, Maenob et al. 
2005) for example M-CSF, a chemokine crucial for the survival and longevity of 
osteoclast precursors (Lorenzo, Horowitz et al. 2008). Furthermore, M-CSF`s 
interaction with RANKL results in the differentiation of pre-osteoclasts to mature 
osteoclasts (Hodge, Collier et al. 2011).  
Macrophages may also express major histocompatibility complex (MHC) class II 
molecules in bony lesion (Kopp and Schwarting 1989) and may therefore contribute 
to lesion development through activation of T-cell-mediated immune responses.  In 
addition, macrophages can act as osteoclast precursors and differentiate into mature 
osteoclasts (Takeshita, Kaji et al. 2000). 
In the present study (paper III), there was a tendency towards increased number 
of  B-cells adjacent to the alveolar bone in infected K14 mice, although not 
significant compared to infected WT mice. The presence of  B-cells together with T 
cells in periodontal lesions is associated with periodontal disease development as 
these cells contribute substantially to production of RANKL (Kawai, Matsuyama et 
al. 2006), a cytokine known to induce osteoclast activity (Wei and Siegal 2008). 
The level of IFN- was significantly elevated in infected K14 mice. IFN- is 
mainly produced by Th1 cells, but also macrophages, B cells (Harris, Haynes et al. 
2000), Natural Killer T cells (Carnaud, Lee et al. 1999) and professional antigen-
presenting cells  (Frucht, Fukao et al. 2001) may secrete IFN-. Concerning 
periodontal disease, IFN- has been shown to inhibit osteoclastogenesis in vitro 
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(Takayanagi et al., 2005; Ji et al., 2009), but this inhibitory effect is overcome in vivo 
because IFN- upregulates the levels of  TNF- and IL-1 which results in an 
increase in RANKL (Gao, Grassi et al. 2007; Graves 2008).  Furthermore, IFN- 
stimulates upregulation of IFN- inducible protein-10 (IP-10), a chemoattractant for 
T- lymphocytes (Taub, Lloyd et al. 1993). In the present study infected K14 mice had 
insignificant but elevated level of the chemokine IP-10 in the periodontal tissue 
compared to infected littermates. IP-10 protein is secreted by various cell types 
including endothelial cells, monocytes, fibroblasts, and keratinocytes in response to 
IFN-  (Luster 1987; Weng, Siciliano et al. 1998). IP-10 has shown to increase the 
infiltration of macrophages (and CD4 T-cells) into inflamed joints and act together 
with RANKL to stimulate bone destruction (Kwak, Ha et al. 2008). 
G-CSF was also significantly increased of in the gingival tissues of infected K14 
mice. G-CSF is crucial for granulocyte production (Villunger, Scott et al. 2003) and 
is secreted by many different cells including bone marrow stromal cells, endothelial 
cells, macrophages and fibroblasts. Pro-inflammatory cytokines such as  IL-1 induce 
G-CSF production (Demetri and Griffin 1991). Besides prolonging neutrophil 
survival (Villunger, Scott et al. 2003), G-CSF also increases macrophages number 
and enhances neutrophil and macrophage phagocytosis (Bermudez, Petrofsky et al. 
1998; Fattorossi, Battaglia et al. 2001). Although neutrophil number was not 
significantly increased in infected K14 mice, they were in close proximity to 
microabcesses found in this strain only. Neutrophils degrade soft tissue and bone 
through degranulation and release of superoxide anion, and are associated with the 
pathogenesis of inflammatory arthritis (Bombini, Canetti et al. 2004). Microabcess 
formation indicates an impaired ability to clear the infection in the mutant infected 
mice.  
The finding that specific P. gingivalis IgG serum level  was lower in infected 
K14 mice than in WT mice is indicative of lower level of adaptive B cell response in 
the former,  probably caused by impaired transport of antigen-presenting cells from 
the oral mucosa toward the lymph nodes after P. gingivalis infection. The weakened 
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humoral immune response may have left the K14 mice more susceptible to develop 
periodontal disease, because a high specific serum IgG is shown to be protective 
against P. gingivalis induced bone loss in mice (Momoi, Hashizume et al. 2008).  
There were no differences in immune cell distribution in cervical lymph nodes 
neither within the strains nor between the strains in any condition. The finding that 
the shams had similar immune cells distribution indicates that presence of lymphatics 
in the gingiva and oral mucosa does not affect lymph nodes immune cells distribution 
in steady state. Furthermore the observation that there were no difference in immune 
distribution in either strain after infection may be due a reduced antigen presenting 
ability in the K14 mice that may have hinder or reduced the infection-induced 
responses. In contrast in the WT mice antigen presentation should be efficient after P. 
gingivalis infection, but the 42 days post-infection observation period was too long to 
observe significant immune cell responses in the local lymph nodes.  
Together, the findings from paper III indicates that the K14 strain which lack 
gingival lymphatics developed a stronger inflammatory response toward alveolar 
bone accompanied by a weakened humoral immune response after P. gingivalis 
infection which might have resulted in enhanced alveolar bone loss observed. 
Lymphatics vessels are therefore crucial for protection against periodontal disease 
probably by clearing the bacteria and bacterial products from gingiva as well as by 
promoting humoral immune responses. 
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6. CONCLUSIONS 
The presented studies in this thesis led to the following conclusions. 
 The gingival lymphatic vessels are important for the transcapillary fluid balance 
under steady-state condition and during acute perturbation.   
 The lymphatic vessels in the alveolar mucosa are not critical in transcapillary fluid 
balance when lymphatic vessels exist in the submucosal layer.  
 Fluid volume expansion is followed by a significant drop in Pif in gingiva, 
suggesting that compliance is increased after disruption of the tissue structure 
during edema formation.  
 Lymphangiogenesis take place in gingival during periodontal disease 
development induced by P.gingivalis, and the lymphatic vessels remain expanded 
after establishment of chronic periodontitis. 
 Vascular endothelial growth factor C in recruited immune cells may contribute to 
the lymphangiogenic response observed after P.gingivalis infection in gingiva.   
 The gingival lymphatic vessels are protective in P. gingivalis induced 
periodontitis in mice, probably by enhancing clearance of bacterial products and 
through promotion of specific humoral IgG responses 
. 
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